Skip to main content

and
  1. Article

    Open Access

    Model to predict cause‐specific mortality in patients with olfactory neuroblastoma: a competing risk analysis

    The main objective of this study was to evaluate the cumulative incidence of cause-specific mortality and other causes of mortality for patients with olfactory neuroblastoma (ONB). The secondary aim was to mod...

    Lipin Liu, Qiuzi Zhong, Ting Zhao, Dazhi Chen, Yonggang Xu in Radiation Oncology (2021)

  2. Article

    Open Access

    Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial

    There is no consensus on the therapeutic approach to ECOG 2 patients with locally advanced non-small-cell lung cancer (LA-NSCLC), despite the sizable percentage of these patients in clinical practice. This stu...

    Nan Bi, Lipin Liu, Jun Liang, Shixiu Wu, Ming Chen, Changxing Lv, Lujun Zhao in BMC Cancer (2020)

  3. Article

    Open Access

    MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma

    Lung adenocarcinoma (LAD) is considered to be a highly aggressive disease with heterogeneous prognosis and the molecular mechanisms underlying tumor progression remain elusive. Growing evidence demonstrates th...

    Lipin Liu, Nan Bi, Lihong Wu, **ao Ding, Yu Men, Wei Zhou, Lin Li in Molecular Cancer (2017)

  4. Article

    Open Access

    Consolidation chemotherapy may improve survival for patients with locally advanced non-small-cell lung cancer receiving concurrent chemoradiotherapy - retrospective analysis of 203 cases

    For patients with locally advanced non-small-cell lung cancer (LA-NSCLC), the role of consolidation chemotherapy (CCT) following concurrent chemoradiotherapy (CRT) is partially defined. The aim of this study w...

    Lipin Liu, Nan Bi, Zhe Ji, Junling Li, **gbo Wang, **aozhen Wang in BMC Cancer (2015)